Rechallenge of immunotherapy beyond progression in patients with extensive-stage small-cell lung cancer

• Main Authors: Lingling Li (Author), Tingting Liu (Author), Qingyan Liu (Author), Shuai Mu (Author), Haitao Tao (Author), Xuhui Yang (Author), Yao Li (Author), Qi Xiong (Author), Lijie Wang (Author), Yi Hu (Author)
• 格式: 圖書
• 出版: Frontiers Media S.A., 2022-09-01T00:00:00Z.
• 主題: article
• 在線閱讀: Connect to this object online.

Background: Rechallenge of immunotherapy beyond progression (RIBP) has been demonstrably effective in a variety of cancers. Our study aims to investigate the efficacy of RIBP in small-cell lung cancer (SCLC) patients under real-world conditions.Methods: SCLC patients who experienced progressive dise...